Gaucher Disease - 48 Studies Found
| Completed |
: A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease to Evaluate Once Daily Versus Twice Daily Dosing (EDGE) : Gaucher Disease : 2010-02-23 : Drug: Eliglustat tartrate Oral Capsule in 50 mg or 100 mg dosages |
| Completed |
: Auto-antibodies Prevalence and CD1 Role in Gaucher Disease : Gaucher Disease : 2016-01-05 : Genetic: genetic analyses |
| Completed |
: A Multicenter Extension Study of Taliglucerase Alfa in Adult Subjects With Gaucher Disease : Gaucher Disease : 2011-08-22 : Drug: Taliglucerase alfa Taliglucerase infusion every two weeks for 21 months |
| Completed |
: Oral Miglustat in Adult Patients With Stable Type 1 Gaucher Disease : Type 1 Gaucher Disease : 2006-04-26 : Drug: miglustat miglustat oral capsules 100mg three times daily (TID) |
| Completed |
: SRT in Comparison to ERT on Immune Aspects and Bone Involvement in Gaucher Disease : Gaucher Disease : 2015-09-09 |
| Completed |
: Comparison of BMD Measurement by DEXA to BeamMed Speed-of-Sound Measurement at Forearm in Patients With Gaucher Disease : Gaucher Disease Type 1 : 2014-01-27 : Device: BeamMed Speed-of-Sound bone strength test at forearm BeamMed Speed-of-Sound bone strength test a |
| Terminated |
: A Study in Type 1 Gaucher Patients to Evaluate the Pharmacokinetics, Safety and Pharmacodynamics of AT2101 : Type 1 Gaucher Disease : 2009-04-02 : Drug: AT2101 225mg (nine 25mg capsules total dose) to be taken by mouth every day for 9 days (Study Days |
| Completed |
: GZ/SAR402671 in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3 : Gaucher Disease Type 1-Gaucher Disease Type 3 : 2016-07-20 : Drug: GZ402671 Other Name: Venglustat |
| Completed |
: The Effect of Velaglucerase Alfa (Vpriv) on Skeletal Development in Pediatric Gaucher Disease :
: 2015-07-28 : Drug: Velaglucerase alfa Enzyme replacement therapy |
| Completed |
: A Long-Term Extension Study of AT2101 in Type 1 Gaucher Patients :
|